Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
publishing date : 2021 - 04 - 21 tags : Vaccine save search
Valneva Initiates Pivotal Phase 3 Clinical Trial for its Inactivated, COVID-19 Vaccine Candidate using Dynavax's CpG 1018™ Adjuvant
Published: 2021-04-21 (Crawled : 23:00) - biospace.com/
DVAX | $11.78 3.88% 3.74% 9.3M
|
Health Technology
|
| O: 1.12%
H: 5.97%
C: 3.87%
covid vaccine phase 3 trial
Global Travel Vaccines Market Report 2021: Hepatitis A/B, DPT, Yellow Fever, Typhoid, Measles and Mumps, Rabies, Meningococcal, Varicella, & Japanese Encephalitis
Published: 2021-04-21 (Crawled : 18:00) - prnewswire.com
NVS | $94.36 1.93% 0.0% 2.3M
|
Health Technology
|
| O: -0.62%
H: 0.56%
C: 0.14%
JNJ | News | $147.91 1.49% -0.03% 9.6M
|
Health Technology
|
| O: -0.45%
H: 0.27%
C: -0.4%
ABT | News | $107.28 1.91% 0.18% 10M
|
Health Technology
|
| O: 0.17%
H: 1.64%
C: 0.56%
SNY | News | $46.32 2.05% 2.01% 3.3M
|
Health Technology
|
| O: -0.93%
H: 0.27%
C: 0.17%
AZN | News | $68.56 0.29% 0.29% 4.7M
|
Health Technology
|
| O: -0.08%
H: 0.06%
C: -0.68%
ALT | $6.91 0.29% 0.29% 3.6M
|
Commercial Services
|
| O: 2.04%
H: 3.44%
C: -0.03%
travel hepatitis vaccine
Researchers Get to Work on Opioid Overuse Vaccine With $25 Million NIH Grant
Published: 2021-04-21 (Crawled : 18:00) - biospace.com/
JNJ | News | $147.91 1.49% -0.03% 9.6M
|
Health Technology
|
| O: -0.07%
H: 0.32%
C: 0.13%
opioid vaccine research granted grant
FDA Asks Emergent to Temporarily Halt J&J COVID-19 Vaccine Ingredient Production
Published: 2021-04-21 (Crawled : 16:00) - biospace.com/
JNJ | News | $147.91 1.49% -0.03% 9.6M
|
Health Technology
|
| O: -0.07%
H: 0.32%
C: 0.13%
covid fda vaccine merge covid-19
Ocugen’s COVID-19 Vaccine Co-Development Partner, Bharat Biotech, Shares Second Interim Results demonstrating 100% Protection against Severe Disease including Hospitalization
Published: 2021-04-21 (Crawled : 14:00) - biospace.com/
OCGN | News A | $1.315 -0.38% -0.38% 6.5M
|
Health Technology
|
| O: 20.47%
H: 1.65%
C: -2.26%
covid disease results biotech vaccine iot
FDA Continues Important Steps to Ensure Quality, Safety and Effectiveness of Authorized COVID-19 Vaccines
Published: 2021-04-21 (Crawled : 13:15) - fda.gov
JNJ | News | $147.91 1.49% -0.03% 9.6M
|
Health Technology
|
| O: -0.07%
H: 0.32%
C: 0.13%
covid fda vaccine authorized covid-19
Vaccinex Announces Publication of Results from CLASSICAL-Lung Phase 1b/2 Clinical Trial in Non-Small Cell Lung Cancer in the Peer-Reviewed Journal Clinical Cancer Research
Published: 2021-04-21 (Crawled : 12:15) - ir.vaccinex.com
VCNX | $4.8 -2.76% 7.9K
|
Health Technology
|
| O: 1.72%
H: 7.2%
C: 5.51%
lung cancer phase 1 results cancer vaccine research trial phase 1b phase 2b
Brii Biosciences, Vir Biotechnology, and VBI Vaccines Announce Initiation of Phase 2 Clinical Trial of BRII-835 (VIR-2218) in Combination with BRII-179 (VBI-2601) for the Treatment of Hepatitis B
Published: 2021-04-21 (Crawled : 12:00) - vbivaccines.com
VIR | $7.96 0.0% 1.1M
|
Health Technology
|
| O: -1.09%
H: 0.38%
C: 0.04%
VBIV | $0.6396 1.57% 1.55% 160K
|
Health Technology
|
| O: 0.0%
H: 7.66%
C: 7.66%
ALNY | $144.315 -0.58% -0.59% 700K
|
Health Technology
|
| O: 0.67%
H: 1.12%
C: 0.43%
treatment phase 2 hepatitis vbi-2601 biotech vaccine technology iot brii-835 trial
Gainers vs Losers
| 67% | 33% |
Top 10 Gainers
AGBA | News | $1.26 215.0% 68.25% 130M
|
Finance
EGOX | $0.0515 43.06% 30.1% 330M
|
OLB 4 | $0.33 -14.95% 25.53% 840K
|
Technology Services
NVFY | $2.77 31.28% 23.83% 33M
|
Consumer Durables
ZCMD | $1.87 28.97% 22.46% 31M
|
Commercial Services
RCON | $0.1112 13.01% 21.28% 1.7M
|
Distribution Services
INSG | $3.03 25.21% 20.13% 330K
|
Electronic Technology
GCTK | $0.8191 22.25% 18.2% 190K
|
Manufacturing
WLGS | $0.59 18.0% 17.9% 2.3M
|
ASNS | $0.828 21.75% 17.86% 18K
|
Your saved searches
Save your searches and get alerts when important news are released.